by Maria Zannes | Oct 2, 2019 | Press Releases
OCTOBER 2, 2019 (San Antonio, TX) bioAffinity Technologies, a privately held biotech company, today announced the members of its Scientific and Medical Advisory (SMA) Board who will provide independent expert advice and counsel on the Company’s research and...
by Maria Zannes | Sep 6, 2019 | Articles, News
AUGUST 29, 2019 As published in the San Antonio Business Journal By W. Scott Bailey – Senior Reporter, San Antonio Business Journal While there is acknowledgment that women have made progress in their climb to executive-level positions in San Antonio’s...
by Maria Zannes | May 15, 2019 | Events
bioAffinity Technologies proudly will present at Advancing Early Lung Cancer Detection at the Cleveland Clinic, an invitation-only symposium that brings together clinical experts, advocacy groups and industry leaders working to advance new technologies and methods...
by Maria Zannes | Mar 12, 2019 | Press Releases
MARCH 12, 2019 (San Antonio, TX) bioAffinity Technologies, a privately held biotech company, today announced the formation of a Scientific and Medical Advisory (SMA) Board to provide independent expert advice and counsel on the Company’s research and development of...
by Maria Zannes | Mar 6, 2019 | Press Releases
MARCH 6, 2019 (San Antonio, TX) Healthcare innovators Lyfebulb and Helsinn selected bioAffinity Technologies, a privately held biotech company developing diagnostics and therapeutics for cancer, as one of 10 finalists for the second annual in Oncology. The Innovation...
